InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 329748

Monday, 06/03/2019 11:55:38 AM

Monday, June 03, 2019 11:55:38 AM

Post# of 345969
Will Oncologie prove out to be just a middle man and squeeze profits away from the longer term PS Targeting shareholders?

John Springs Stafford and Ronin look like they will be ok paying bigger fines and all to delay and slow play PS Targeting

More and more MOA of Big Pharma Drugs are going to realize that flipped PS is targeted first ...and MOAs of other drugs may have to be overturned

Laura E Benjamin all over Biothera and who on our BOD likes Sensient ? I guess we may now debate how Independent Joseph Carleone truly is...

https://www.sensientflavorsandfragrances.com/images/uploads/pdf/BiotheraPartner.pdf

_____

Joseph Carleone biography

Dr. Joseph Carleone, Ph.D. is Independent Director of the Company. Dr. Carleone is Chairman of the Board of AMPAC Fine Chemicals LLC (since December 2015), a leading manufacturer of pharmaceutical active ingredients. Prior to this position, Dr. Carleone was President and Chief Executive Officer of American Pacific Corporation (2010 to 2015), a leading custom manufacturer of fine and specialty chemicals and propulsion products. While at American Pacific Corporation, he also served as President and Chief Operating Officer (2006 to 2009), as a director (2006 to 2015), and as Chairman of the Board (March 2013 to February 2014, when it was acquired by H.I.G. Capital, LLC). Dr. Carleone has also served or currently serves as an officer and/or a director of several directly or indirectly wholly-owned subsidiaries of American Pacific Corporation. Since November 27, 2017, Dr. Carleone has served as a director of Avid Bioservices, Inc. (formerly known as Peregrine Pharmaceuticals, Inc.) (NASDAQ: PPHM). After his election as a director, he was named non-executive Chairman of Avid Bioservices’ Board of Directors. Avid Bioservices is a clinical stage biopharmaceutical company focused on developing therapeutics to stimulate the body’s immune system to fight cancer. Dr. Carleone received his bachelor’s degree in Mechanical Engineering from Drexel University, Philadelphia, Pennsylvania, in 1968; his masters’ degree in Applied Mechanics from Drexel University in 1970; and his doctorate degree in Applied Mechanics from Drexel University in 1972.

https://www.google.com/amp/s/wallmine.com/people/42102/joseph-carleone.amp
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News